Navigation Links
CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium
Date:1/15/2008

Company to also Present at Stanford Group 13th Annual Healthcare Conference

SAN DIEGO, Jan. 15 /PRNewswire-FirstCall/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today that it will showcase its Cardiac Cryoablation System and its next generation ablation catheter, Quantum, at the Boston Atrial Fibrillation Symposium, January 17-19, 2008. CryoCor's products will be located at Booth 801.

In August 2007, the FDA approved the Cryoablation System for the treatment of right atrial flutter and CryoCor completed enrollment of its pivotal clinical study of the System for the treatment of atrial fibrillation. The Company has completed animal studies with Quantum, which is designed to significantly reduce the required time for an atrial fibrillation catheter ablation. CryoCor expects to enter human trials with Quantum in the second quarter of 2008.

Ed Brennan, Ph.D., President and Chief Executive Officer of CryoCor, said, "The Boston AF Symposium is the premier industry event focused on the treatment of atrial fibrillation, and as such, offers a tremendous forum to showcase our products to potential users. We look forward to the opportunity to increase the knowledge of our Cryoablation System and the unique advantages our technology provides physicians."

The Company also announced that Edward F. Brennan, President and Chief Executive Officer, and Gregory J. Tibbitts, Chief Financial Officer, are scheduled to present at the Stanford Group 13th Annual Healthcare Conference in Washington, D.C. on Thursday, January 17, 2008 at 7:45 a.m. ET at The Four Seasons Hotel.

A live Web cast and recording of the presentation will be available online from the investor relations page of the Company's corporate Web site at http://www.cryocor.com. The recording will remain available on CryoCor's Web site for at least 30 days following
'/>"/>

SOURCE CryoCor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. CryoCor to Present at CIBC World Markets 18th Annual Healthcare Conference
2. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
3. Highlights of Economic and Business Growth in the Tampa Bay Region
4. Highlights of Economic and Business Growth in the Tampa Bay Region
5. Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
6. Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
7. Arius highlighted at AACR-NCI-EORTC 2007 International Cancer Conference
8. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
9. Highlights of Economic and Business Growth in the Tampa Bay Region
10. Access Highlighted in Recent BusinessWeek Article
11. Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Societys 29th Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Varian Medical Systems today broke ground ... Lake City manufacturing facility and allow for the consolidation ... create 1,000 new full time jobs in the state ... home to hardworking people with immense engineering and technical ... success in the manufacturing of our state-of-the-art X-ray technology,” ...
(Date:8/27/2014)... NEW YORK , Aug. 27, 2014 ... market research report is available in its ... Market 2014-2018 http://www.reportlinker.com/p02316661/Global-Biodegradable-Packaging-Materials-Market-2014-2018.html ... Biodegradable materials are materials that are readily ... packaging differs from conventional non-degradable packaging in ...
(Date:8/27/2014)... 27, 2014 Reportlinker.com announces that a ... catalogue: Global Chelating Agents Market 2014-2018 ... About Chelating Agent A chelating agent is a ... metal ions, thereby forming a metal-ion complex. It ... on chemical processes, formulations, and the environment by ...
(Date:8/27/2014)... 27, 2014 “We are honored to ... said Ven Thangaraj, CEO of Radiant Sage. “We are ... taking the imaging corelab market to a different level. ... research organizations to efficiently and effectively manage the massive ... to be analyzed and read by trained physicians. Being ...
Breaking Biology Technology:Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3Global Biodegradable Packaging Materials Market 2014-2018 2Global Biodegradable Packaging Materials Market 2014-2018 3Global Biodegradable Packaging Materials Market 2014-2018 4Global Biodegradable Packaging Materials Market 2014-2018 5Global Biodegradable Packaging Materials Market 2014-2018 6Global Biodegradable Packaging Materials Market 2014-2018 7Global Chelating Agents Market 2014-2018 2Global Chelating Agents Market 2014-2018 3Global Chelating Agents Market 2014-2018 4Radiant Sage Named to CIOReview List of 100 Most Promising Technology Companies 2
... Arpida Ltd.,(SWX: ARPN) announces today that it ... Food and Drug Administration (FDA) regarding its New ... of complicated,skin and skin structure infections (cSSSI). The ... the application for iclaprim in its current form ...
... six genome centres demonstrated the power of partnerships ... at the International Plant and Animal Genomics Conference ... researchers, funders and other international stakeholders enjoyed Canadian ... event. , "This Canadian reception was a truly ...
... Fla. --- Algae is a livid green giveaway of nutrient ... action in tiny particles that would turn different colors if ... health in the blood. , Now, University of Florida engineering ... a major hurdle to creating such "smart dust.",The feat, which ...
Cached Biology Technology:FDA Issues Complete Response Letter for Iclaprim 2Researchers: Molecular forklifts overcome obstacle to 'smart dust' 2Researchers: Molecular forklifts overcome obstacle to 'smart dust' 3
(Date:8/27/2014)... understanding the mysteries of the human genome was unveiled ... the most detailed comparison yet of how the genomes ... , The research, appearing August 28 in in the ... in the three species, genomes is "read out," and ... , The results add billions of entries to a ...
(Date:8/27/2014)... effective doses of the HIV drug maraviroc, a new ... completed before the drug was licensed in 2007, included ... key to removing maraviroc from the body. The current ... protein including nearly half of African-Americans end ... those who lack the protein even when given the ...
(Date:8/27/2014)... LAKE CITY, Aug. 27, 2014 University of Utah ... his native Turkey, has won that nation,s highest science ... of Science. , Sekercioglu is among five researchers picked ... and Technical Research Council of Turkey. Three researchers won ... won the Special Award, which is equivalent to the ...
Breaking Biology News(10 mins):Encyclopedia of how genomes function gets much bigger 2Encyclopedia of how genomes function gets much bigger 3Encyclopedia of how genomes function gets much bigger 4Dosage of HIV drug may be ineffective for half of African-Americans 2University of Utah biologist wins Turkey's top science prize 2
... - NOVEMBER 6, 2013: In an ... a New York-based physician-researcher from the Touro College of Osteopathic ... for levels of a growth protein that could help predict ... an analysis of findings in prior published studies, Touro researcher ...
... Mo. Researchers from the University of Missouri have ... cancer, the fourth leading cause of cancer death in ... deaths each year in the United States, and kills ... years, according to the National Cancer Institute. ...
... and largest of its kind study focusing on the ... in JAMA Pediatrics . The "Teen Longitudinal ... the National Institutes of Health (NIH) and is being ... Children,s Hospital. Thomas H. Inge, MD, PhD, with ...
Cached Biology News:Breastfeeding as a possible deterrent to autism -- a clinical perspective 2Breastfeeding as a possible deterrent to autism -- a clinical perspective 3MU study finds more accurate method to diagnose pancreatic cancer 2Findings announced from landmark study on safety of adolescent bariatric surgery 2
Mouse monoclonal to OCIL ( Abpromise for all tested applications)....
... antigen initiates replication from the ... the presence of the host ... be used in conjunction with ... cat. no. 8050. For ...
NuParaffin Kit Application: Flow Cytometry Reactivity: Human...
Request Info...
Biology Products: